General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss $ (1,433,626) $ (928,888) $ (3,650,740) $ (3,076,873) $ (4,024,222) $ (1,985,234)
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation and amortization 10,074 6,718 29,102 23,853 30,569 29,422
Amortization of debt discount     129,256    
Stock based compensation 175,712 180,562 534,774 443,249 650,271 242,146
Bad debt expense on note receivable and accrued interest     89,933 89,933
Loss on abandonment of patents 36,205 36,205    
Change in fair value of derivative liability 20,524 3,139    
Changes in assets and liabilities:            
Accounts receivable     32,333 (193,168) 181,960 (37,243)
Inventories     172,653 14,251 97,736 (329,598)
Deposits and other assets     (118,168) (118,168) 32,045
Prepaid expenses     (21,013) (1,214) (1,245) (2,919)
Accrued payroll and payroll related expenses     43,801 55,230 39,421 (20,239)
Accounts payable and accrued expenses     (350,650) 50,752 (146,784) (9,003)
Accrued separation costs     (6,750)    
Net cash used in operating activities     (3,047,889) (2,712,155) (3,200,528) (2,080,623)
CASH FLOWS FROM INVESTING ACTIVITIES:            
Increase in intangible assets     (58,394) (30,483) (36,593) (19,408)
Net cash used in investing activities     (58,394) (30,483) (36,593) (19,408)
CASH FLOWS FROM FINANCING ACTIVITIES:            
Proceeds from the issuances of related party notes payable     1,575,000    
Proceeds from the issuance of a related party convertible note payable     750,000    
Proceeds from the issuances of convertible notes payable     300,000    
Proceeds from the issuance of common stock     245,000 704,375 1,244,037 4,138,435
Proceeds from the exercise of warrants         40,000
Net cash provided by financing activities     2,870,000 704,375 1,244,037 4,178,435
NET DECREASE IN CASH     (236,283) (2,038,263) (1,993,084) 2,078,404
BEGINNING OF THE PERIOD     243,753 2,236,837 2,236,837 158,433
END OF THE PERIOD $ 7,470 $ 198,574 7,470 198,574 243,753 2,236,837
SUPPLEMENTAL DISCLOSURES:            
Cash paid for interest     13,937 3,356 4,227 3,537
Cash paid for income taxes    
NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Discount recognized on notes payable at issuance     384,710    
Conversion of accounts payable into restricted stock         44,700
Settlement of receivables with payables     60,670 221,814 301,799
Purchases of inventory in accounts payable         $ 1,237,691
Right to use assets funded through leases     $ 22,015 $ 539,662